Asia Pacific Companion Diagnostics market

Synopsis
The above chart is Global Companion Diagnostics market [2016-2027] by Asia Pacific

Market Dynamics

China accounted for the largest market share in 2019 in the asia pacific companion diagnostics market, and is expected to reach usd 587.62 million in 2027 from usd 229.20 million in 2019. however, india is the fastest growing market, which is expected to grow at a cagr of 26.08% during the forecast period 2020 - 2027. assays kits and reagents segment accounted for the larger market share in 2019, this market is expected to reach usd 1556.01 million in 2027 from usd 567.35 million in 2019. this market is projected to grow at a cagr of 23.47% during the forecast period from 2020 - 2027. however, assays kits and reagents segment is the fastest growing market, which is expected to grow at a cagr of 23.47% during the forecast period 2020 - 2027. polymerase chain reaction pcr segment accounted for the largest market share in 2019, this market is expected to reach usd 871.71 million in 2027 from usd 328.47 million in 2019. this market is projected to grow at a cagr of 23.49% during the forecast period from 2020 - 2027. however, next generation sequencing ngs segment is the fastest growing market, which is expected to grow at a cagr of 24.54% during the forecast period 2020 - 2027. pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2019, this market is expected to reach usd 891.29 million in 2027 from usd 358.72 million in 2019. this market is projected to grow at a cagr of 21.98% during the forecast period from 2020 - 2027. however, contract research organizations segment is the fastest growing market, which is expected to grow at a cagr of 24.30% during the forecast period 2020 - 2027. cancer segment accounted for the largest market share in 2019, this market is expected to reach usd 1577.08 million in 2027 from usd 594.43 million in 2019. this market is projected to grow at a cagr of 23.00% during the forecast period from 2020 - 2027. however, infectious diseases segment is the fastest growing market, which is expected to grow at a cagr of 23.07% during the forecast period 2020 - 2027.